Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Allergan returns rBPI ophthalmic rights to Xoma

Nov. 20, 2000

Positive phase II results reported for INS-365 as dry eye disease treatment

Nov. 14, 2000

October launch for Rescula, a new docosanoid for glaucoma, in U.S.

Nov. 3, 2000

Allergan's novel glaucoma drug nears clinical trials

Nov. 2, 2000

Update on Pharmacia's ocular medications

Oct. 24, 2000

Protective effect demonstrated for SKK-60060 in rat model of retinal ischemia-reperfusion

Oct. 23, 2000

Ciba Vision and QLT seek to expand Visudyne indication in the E.U.

Oct. 5, 2000

New series from Senju particularly useful for ocular disorders

Oct. 4, 2000

New ocular hypotensive agents in the Alcon pipeline

Sep. 8, 2000

New agents for glaucoma reported by Santen

Sep. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...